{"gene":"PDGFB","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1984,"finding":"The c-sis proto-oncogene encodes a precursor of the B chain of platelet-derived growth factor (PDGF-B), as established by amino acid sequence identity between PDGF B chain and the predicted protein from c-sis genomic sequences over 109 residues.","method":"Amino acid sequence analysis of purified PDGF B chain combined with nucleotide sequence analysis of c-sis genomic clones","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct protein sequencing matched to gene sequence; foundational finding independently consistent with multiple subsequent studies","pmids":["6329745"],"is_preprint":false},{"year":1984,"finding":"SSV-transformed cells secrete a PDGF-like protein (p28v-sis or its processed product) that stimulates autocrine cell growth through cell-surface PDGF receptors; anti-PDGF antisera block DNA synthesis in growing SSV-transformed cells and SSV-transformed cells have reduced numbers of high-affinity PDGF receptors; purified PDGF receptor from SSV cells retains active protein tyrosine kinase activity stimulated by PDGF.","method":"Mitogenic assays, 125I-PDGF receptor competition binding, anti-PDGF antisera inhibition of 3H-thymidine incorporation, receptor purification with tyrosine kinase activity assay","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal functional assays; receptor purification with biochemical activity confirmed; replicated conceptually across multiple studies","pmids":["6091918"],"is_preprint":false},{"year":1985,"finding":"The v-sis gene product transforms cells by binding to PDGF receptors, stimulating tyrosine phosphorylation of PDGF receptors, and inducing DNA synthesis; transformation susceptibility strictly correlates with the presence of PDGF receptors on the target cell; antibodies to different regions of the v-sis product specifically inhibit each of these activities.","method":"Partial purification of v-sis protein, PDGF receptor binding assay, tyrosine phosphorylation assay, DNA synthesis induction, antibody inhibition, viral infection of receptor-positive vs. receptor-negative cell types","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal biochemical assays with antibody-based functional inhibition; receptor requirement demonstrated by cell-type correlation","pmids":["2996133"],"is_preprint":false},{"year":1986,"finding":"The v-sis gene product is processed through the endoplasmic reticulum-Golgi compartment where signal sequence cleavage and N-linked glycosylation occur; the protein contains no transmembrane regions (fully protected from trypsin within microsomes); site-directed mutagenesis of the signal sequence produces proteins with nuclear mislocalization and loss of biological activity; mutagenesis of the proteolytic processing site (Lys-Arg 110-111 to Asn-Ser) retains full biological activity.","method":"Site-directed mutagenesis, intracellular fractionation, trypsin protection assay of isolated microsomes, indirect immunofluorescence, biological transformation assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis combined with subcellular fractionation and functional assay; single lab but multiple orthogonal methods","pmids":["3537701"],"is_preprint":false},{"year":1986,"finding":"Transmembrane (membrane-anchored) forms of the v-sis gene product are transported to the cell surface, dimerize, are glycosylated, and undergo NH2-terminal proteolytic processing; removal of the N-linked glycosylation site does not prevent cell surface transport; membrane-anchored mutants retain focus-forming (transforming) activity.","method":"Gene fusion construction, indirect immunofluorescence, focus formation assay, N-glycosylation site mutagenesis","journal":"The Journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct localization by immunofluorescence linked to functional transformation assay; single lab, multiple methods","pmids":["3536965"],"is_preprint":false},{"year":1988,"finding":"Autocrine stimulation by v-sis (PDGF-B-related protein) requires a ligand-receptor interaction at the cell surface: monensin (blocking secretory transport) and suramin (blocking cell-surface receptor binding) each prevent PDGF receptor autophosphorylation and c-fos induction triggered by v-sis expression, indicating the active signaling event occurs at the plasma membrane rather than intracellularly.","method":"Inducible v-sis expression (heat-shock promoter), PDGF receptor autophosphorylation assay, c-fos induction assay, monensin and suramin pharmacological inhibition","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — two independent pharmacological interventions each blocking downstream readouts; inducible expression system with defined temporal control","pmids":["2455725"],"is_preprint":false},{"year":1989,"finding":"Transformation by v-sis occurs through an internal autoactivation mechanism: a v-sis mutant targeted for retention in the ER/Golgi (non-secreted) transforms NRK cells as efficiently as wild-type v-sis, and anti-PDGF antisera do not reverse transformation of SSV-NRK cells, demonstrating that intracellular (pre-surface) activation of the PDGF receptor is sufficient for transformation.","method":"ER-retention signal mutagenesis of v-sis, focus formation/transformation assay, anti-PDGF antisera treatment of transformed cells, secretion assay","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — genetic engineering of targeting signal, functional transformation assay, antibody blockade negative control; contradicts the pure autocrine surface model","pmids":["2551043"],"is_preprint":false},{"year":1989,"finding":"The 5' untranslated region of c-sis mRNA (1028 nt) contains sequences that inhibit protein synthesis; deletion of nucleotides 154-378 or 398-475 relieves this inhibition; sequences within 375 nt upstream of the RNA initiation site control transcriptional activity, and a transcriptional enhancer within this region is orientation-independent and responds to the HTLV-I transactivator protein.","method":"Deletion mutagenesis of 5'UTR in translation assays, CAT reporter gene transcriptional assays, HTLV-I transactivator co-transfection","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro functional assays with deletion mutants; single lab, mechanistic but not independently replicated","pmids":["2740212"],"is_preprint":false},{"year":1989,"finding":"c-sis mRNA expression in glioblastoma cells is induced by phorbol ester (PMA) and TGF-β1 via transcriptional mechanisms (confirmed by nuclear run-on); PMA induction is protein-kinase C (PKC)-dependent while TGF-β1 induction is PKC-independent; both pathways are blocked by the protein kinase inhibitor H7, implicating a non-PKC kinase in TGF-β1 signaling to c-sis.","method":"Nuclear run-on transcription assay, PKC down-regulation, cycloheximide treatment, kinase inhibitors (H7), RNA-RNA solution hybridization","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — nuclear run-on confirms transcriptional mechanism; pharmacological pathway dissection with multiple agents; single lab","pmids":["2655888"],"is_preprint":false},{"year":1990,"finding":"PDGF-B/sis induces a DNA-binding protein (SIF, sis-inducible factor) that binds a conserved element (SIF binding element, ~-100 to -57 of c-fos) and confers PDGF-B-specific transcriptional inducibility on the c-fos promoter; this element functions independently of the serum-responsive element (SRE) and responds only to sis/PDGF (not to serum or phorbol esters); SRE and SIF elements act additively.","method":"Conditioned medium and recombinant PDGF-B induction, gel mobility-shift/DNA binding assays, oligonucleotide competition, promoter-reporter transfection with deletion/mutation analysis","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — recombinant PDGF-B used; DNA-protein interaction combined with functional promoter assay; multiple orthogonal methods in one study","pmids":["2176154"],"is_preprint":false},{"year":1986,"finding":"Phorbol ester (TPA) induces c-sis transcription in the K-562 hematopoietic stem cell line (megakaryoblastic differentiation), as demonstrated by nuclear run-off transcriptional assay; this induction is not a general effect of TPA on hematopoietic cells.","method":"Northern blot analysis, nuclear run-off transcriptional assay, TPA treatment of multiple hematopoietic cell lines","journal":"Molecular and cellular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — nuclear run-off confirms transcriptional induction; single lab, single cell-type focus","pmids":["3466024"],"is_preprint":false},{"year":1993,"finding":"A 10-bp element (SIS proximal element, SPE) at positions -58 to -39 relative to the PDGFB mRNA initiation site is essential for TPA-induced transcriptional activation of PDGFB in megakaryocytes; TPA treatment induces formation of a new nuclear protein complex on the SPE that coincides temporally with endogenous PDGFB mRNA induction; both are blocked by cycloheximide, indicating a requirement for new protein synthesis.","method":"Linker-scanning mutagenesis of PDGFB promoter, luciferase reporter assay, gel mobility-shift assay with K562 nuclear extracts, cycloheximide inhibition, TPA induction time course","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — systematic mutagenesis across the promoter combined with protein-DNA binding and functional reporter assay; multiple orthogonal methods","pmids":["8356057"],"is_preprint":false},{"year":1994,"finding":"Selective PDGF receptor kinase inhibitors (tyrphostins AG1295 and AG1296) reverse the transformed phenotype of sis-transfected NIH 3T3 cells but have no effect on src-transformed cells, confirming that sis-driven transformation is mediated specifically through PDGF receptor kinase activity.","method":"Tyrphostin treatment of sis-transfected NIH 3T3 cells (phenotypic reversion assay), autophosphorylation assays for PDGF-Rα/β, KDR, and c-Src, DNA synthesis assays","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — selective pharmacological inhibitors with parallel positive (src) and negative (PDGFR) controls; receptor specificity profiled across multiple kinases","pmids":["7954456"],"is_preprint":false},{"year":1998,"finding":"In dermatofibrosarcoma protuberans (DFSP) and giant-cell fibroblastomas, COL1A1-PDGFB chimeric genes always include exon 2 of PDGFB fused to varying exons of COL1A1's alpha-helical domain, placing PDGFB under the COL1A1 promoter and removing negative regulatory elements of PDGFB; retention of exon 2 in all fusions suggests it is required for normal PDGFB polypeptide processing.","method":"RT-PCR and DNA sequence analysis of chimeric transcripts from 16 DFSP/GCF tumors, Southern blotting, breakpoint mapping","journal":"Genes, chromosomes & cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — molecular characterization across 16 tumors; consistent fusion architecture implies functional constraint on exon 2 retention, but mechanism of processing not directly tested","pmids":["9739023"],"is_preprint":false},{"year":2001,"finding":"The COL1A1-PDGFB chimeric protein is processed in transfected cells into mature PDGFB dimers; stable expression of COL1A1-PDGFB confers growth factor independence and tumorigenicity in nude mice; conditioned medium stimulates fibroblast growth through PDGFB receptor activation; uncleaved COL1A1-PDGFB forms are also mitogenic, indicating both processed and unprocessed forms contribute to transformation.","method":"Stable and transient transfection of chimeric cDNA in PS200 and HEK293 cells, anti-PDGFB and anti-COL1A1-PDGFB antibody immunodetection, PDGFB receptor pathway activation assay, nude mouse tumorigenicity assay, mutagenesis of proteolytic cleavage site","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — reconstitution in cell lines with multiple antibody-based readouts, receptor activation assay, in vivo tumorigenicity, and mutagenesis; multiple orthogonal approaches","pmids":["11420709"],"is_preprint":false},{"year":2001,"finding":"STI571 (imatinib) inhibits the PDGFB autocrine loop driven by COL1A1-PDGFB, reducing growth and reversing the transformed phenotype of COL1A1-PDGFB-expressing cells in vitro and slowing pre-existing tumor growth in vivo; effects are cytostatic (reversible) rather than cytotoxic, unlike the cytotoxic effect on BCR-ABL tumors.","method":"STI571 treatment of 5A cell line (COL1A1-PDGFB transfectants), in vitro growth and morphology assay, nude mouse xenograft tumor growth assay, inhibitor washout reversal experiment","journal":"International journal of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo pharmacological validation; reversibility confirmed; single lab","pmids":["11291071"],"is_preprint":false},{"year":2005,"finding":"PDGF-B signaling induces cytoplasmic relocalization (nuclear-to-cytoplasmic shuttling) and upregulation of Y-box protein 1 (YB-1) in mesangial cells via the MAPK pathway; RNAi knockdown of YB-1 abolishes the mitogenic effect of PDGF-B, establishing YB-1 as a necessary downstream mediator of PDGF-B-driven mesangial cell proliferation.","method":"PDGF-B infusion in vivo, anti-Thy1.1 nephritis model, PDGF aptamer and MEK inhibitor (U0126) treatment, YB-1 immunolocalization, RNAi knockdown with proliferation assay","journal":"Journal of the American Society of Nephrology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway placement via inhibitor and RNAi; in vivo and in vitro corroboration; single lab","pmids":["16093451"],"is_preprint":false},{"year":2011,"finding":"SDF-1α induces PDGF-B expression transcriptionally through the ELK-1 transcription factor binding to the pdgf-b promoter; increased PDGF-B in turn drives differentiation of PDGFR-β+ bone marrow cells into pericytes, establishing SDF-1α→ELK-1→PDGF-B as a pathway controlling pericyte differentiation.","method":"PDGF-B mRNA/protein measurement in vitro and in vivo after SDF-1α stimulation, cloning of 2-kb pdgf-b promoter with reporter assay, chromatin immunoprecipitation (ChIP) for ELK-1, in vitro pericyte differentiation assay","journal":"Molecular cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP identifies ELK-1 at promoter; promoter-reporter confirms transcriptional mechanism; in vitro differentiation assay; single lab","pmids":["21911740"],"is_preprint":false},{"year":2013,"finding":"TIE2 mutations causing venous malformations reduce PDGFB production in endothelial cells through chronic, ligand-independent AKT activation; reduced PDGFB secretion is demonstrated both in vitro and ex vivo in patient tissues, providing a mechanism for the paucity of vascular smooth muscle cells in these lesions.","method":"Global gene expression profiling of TIE2-mutant ECs, PDGFB mRNA/protein quantification in vitro and ex vivo, AKT pathway inhibition rescue experiment","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pathway inhibition links AKT to PDGFB; both in vitro and ex vivo patient tissue validation; single lab","pmids":["23633549"],"is_preprint":false},{"year":2015,"finding":"All six analyzed PDGFB loss-of-function mutations causing primary familial brain calcification (PFBC) abolish PDGF-B function either by preventing protein synthesis or by defective binding/stimulation of PDGF-Rβ; Pdgfbret/ret mice (lacking proteoglycan-binding retention motif) develop brain calcifications despite higher pericyte coverage in calcification-prone regions, implicating the tissue-retention function of PDGF-B rather than simple pericyte deficit.","method":"In vitro functional analysis of PDGFB mutants (receptor binding and autophosphorylation assays), mouse knockout and knockin models (Pdgfbret/ret), pericyte coverage quantification, BBB permeability assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple PDGFB mutations functionally characterized in vitro; mechanistic dissection with multiple mouse models; multi-method approach","pmids":["26599395"],"is_preprint":false},{"year":2017,"finding":"PDGFB secreted by lymphatic endothelial cells (LECs) of collecting vessels is required for smooth muscle cell (SMC) recruitment to lymphatic vessels; LEC-specific deletion of Pdgfb prevents SMC investment, causing dilation and loss of pulsatile contraction without affecting vessel identity; PDGFB extracellular matrix retention (via its ECM-binding motif) is required for SMC recruitment, as overexpression in LECs fails to induce SMC coverage of capillaries where PDGFB-binding ECM components are scarce.","method":"LEC-specific Pdgfb conditional knockout mice, PDGFB overexpression in LECs, vessel morphology and pulsatile contraction analysis, ECM retention mutant analysis","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO with defined vascular phenotype; overexpression confirms requirement for ECM retention motif; multiple vascular beds examined","pmids":["28851707"],"is_preprint":false},{"year":1994,"finding":"PDGF-B (via v-sis) induces Egr-1 expression through a pathway involving tyrosine kinase activity and c-Ha-Ras signaling: dominant-negative Ras and Raf abolish Egr-1 induction by v-sis; the pathway is independent of PKC; Egr-1 promoter activity is stimulated by both v-sis and activated Ras but not by constitutively active Ras.","method":"Inducible v-sis NIH3T3 cells (metallothionein promoter), dominant-negative Ras and Raf mutant co-transfection, Egr-1 promoter-reporter assay, Zn2+ dose-response","journal":"Journal of cellular biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis with dominant-negative mutants; promoter-reporter and endogenous gene expression correlated; single lab","pmids":["7890805"],"is_preprint":false},{"year":2019,"finding":"PDGF-B deficiency (Pdgfbret/ret mouse, loss of proteoglycan-binding retention motif) suppresses glymphatic system development; formation of astrocytic endfeet and polarized AQP4 expression coincides with the emergence of perivascular CSF transport, and PDGF-B is required for this developmental process.","method":"Pdgfbret/ret mouse model, CSF tracer injection/imaging of perivascular transport, AQP4 polarization immunostaining, developmental time-course analysis","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined mouse genetic model with specific functional readout (perivascular CSF flow); correlative with AQP4 polarization; single lab","pmids":["30865886"],"is_preprint":false},{"year":2020,"finding":"Platelet-specific conditional knockout of PDGFB impairs pericyte coverage and tumor vascular function, increases hypoxia and EMT in primary tumors, elevates circulating tumor cells, and increases spontaneous metastasis, establishing platelet-derived PDGFB as a source that maintains vascular integrity via pericyte recruitment in tumors.","method":"Platelet-specific conditional Pdgfb knockout mice, tumor pericyte coverage quantification, tumor vascular function assays, circulating tumor cell measurement, spontaneous metastasis assay in two mouse models","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO; multiple vascular and metastatic readouts; two independent mouse tumor models","pmids":["32586981"],"is_preprint":false},{"year":2021,"finding":"Microglia constitutively release PDGFB, which signals via PDGFRα on hypothalamic pre-sympathetic neurons to promote Kv4.3 (potassium channel) expression; ablation of microglia or microglial-specific deletion of Pdgfb reduces neuronal Kv4.3, increases neuronal excitability and sympathetic outflow, causing hypertension; central PDGFB supplementation suppresses hypertensive responses.","method":"Microglial ablation, LysM-Cre conditional Pdgfb knockout, neuronal PDGFRα knockdown in PVN, electrophysiology, Kv4.3 expression analysis, blood pressure measurement, exogenous PDGFB infusion","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal genetic models (ablation, conditional KO, receptor knockdown); electrophysiology confirms neuronal excitability change; rescue experiment with exogenous PDGFB","pmids":["35863346"],"is_preprint":false},{"year":2021,"finding":"Macrophage-derived PDGF-B mediates hypoxia-induced distal arteriole muscularization (SMC accumulation) in pulmonary hypertension; hypoxia-inducible factors (HIF-1α/HIF-2α) in macrophages drive Pdgfb upregulation; LysM-Cre conditional deletion of macrophage Pdgfb reduces muscularization and PH; nanoparticle siRNA delivery targeting lung macrophage Pdgfb prevents PH.","method":"Clodronate macrophage depletion, LysM-Cre conditional HIF-1α, HIF-2α, and Pdgfb knockout mice, VHL knockout (HIF gain-of-function) mouse, macrophage-conditioned medium SMC proliferation/migration assay, nanoparticle siRNA delivery, right heart catheterization","journal":"JCI insight","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent genetic models; cell-type-specific KO with defined PH phenotype; conditioned medium mechanistic assay; therapeutic rescue with siRNA nanoparticles","pmids":["33591958"],"is_preprint":false},{"year":2021,"finding":"Adult-induced endothelial deletion of Pdgfb causes slowly progressing pericyte loss (~50% endothelial:pericyte ratio decrease at 12-18 months) with increased BBB permeability; unlike constitutive loss, adult-induced loss does not cause vessel dilation, arterio-venous skewing, or microvascular calcifications, establishing that developmental vs. maintenance roles of PDGFB are distinct.","method":"Tamoxifen-inducible endothelial Cre Pdgfb conditional knockout (2-month-old mice), longitudinal pericyte coverage quantification, BBB permeability assay, vessel morphology analysis, comparison with constitutive Pdgfb knockout","journal":"Journal of cerebral blood flow and metabolism","confidence":"High","confidence_rationale":"Tier 2 / Strong — temporally controlled conditional KO with longitudinal readouts; direct comparison with constitutive KO dissects developmental vs. maintenance functions; multiple quantitative endpoints","pmids":["34689641"],"is_preprint":false},{"year":2023,"finding":"In adult mice, microglia (not endothelial cells) are the primary source of PDGFB for BBB maintenance; acute deletion of microglial PDGFB profoundly impairs adult BBB integrity and causes fatal microhemorrhages after sublethal endotoxin challenge, while acute abrogation of endothelial PDGFB has minimal adult BBB effect but severely impairs neonatal CNS vasculature; microglia upregulate PDGFB in response to various BBB insults.","method":"Transcriptomic analysis and in situ hybridization for PDGFB source identification, acute microglial Pdgfb conditional knockout, acute endothelial Pdgfb conditional knockout in adults and neonates, BBB integrity assay, endotoxin challenge survival assay","journal":"Brain, behavior, and immunity","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional KO in adults vs. neonates; multiple genetic models; in situ hybridization for source; functional BBB and survival readouts","pmids":["37992789"],"is_preprint":false},{"year":2013,"finding":"E2F1 transcriptionally activates PDGF-B expression through a positive feedback loop with VEGF-C/VEGFR-3: E2F1 or VEGFR-3 knockdown reduces PDGF-B levels, while coexpression of E2F1 and VEGFR-3 synergistically upregulates PDGF-B promoter activity and endogenous protein expression.","method":"E2F1 forced expression and knockdown, VEGFR-3 knockdown, PDGF-B promoter-reporter assay, Western blot for endogenous PDGF-B, in vivo neovascularization assay in mice","journal":"Journal of molecular cell biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter-reporter and knockdown of upstream regulators; synergistic coexpression; in vivo corroboration; single lab","pmids":["24014887"],"is_preprint":false},{"year":2023,"finding":"PROX1 transcriptionally represses PDGF-B expression in valvular endothelial cells partly via FOXC2; conditional deletion of Prox1 in VECs upregulates PDGF-B and PDGF-B overexpression in VECs recapitulates myxomatous valve degeneration; pharmacological inhibition of PDGF-B signaling with imatinib partially rescues the Prox1 knockout valve phenotype.","method":"Conditional Prox1 knockout in VECs, conditional FOXC2 knockdown, conditional PDGF-B overexpression in VECs, echocardiography, histology, imatinib pharmacological rescue, RNAScope, human mitral valve prolapse sample analysis","journal":"Circulation research","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent genetic models; pharmacological rescue; human tissue validation; multiple orthogonal phenotypic readouts","pmids":["37555328"],"is_preprint":false},{"year":2021,"finding":"C/EBPβ directly binds to and transactivates the PDGFB promoter in anoikis-resistant gastric cancer cells, increasing PDGFB secretion; secreted PDGFB promotes survival of detached cancer cells via a C/EBPβ-dependent self-feedback loop (autocrine) and promotes angiogenesis via activation of MAPK/ERK signaling in vascular endothelial cells (paracrine).","method":"PDGFB promoter ChIP and transcription assay with C/EBPβ, PDGFB secretion quantification, autocrine survival assay in suspension, paracrine endothelial MAPK/ERK activation assay, in vivo peritoneal metastasis models","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP confirms direct promoter binding; functional autocrine and paracrine assays; in vivo validation; single lab","pmids":["34341514"],"is_preprint":false},{"year":1999,"finding":"Cyclic mechanical strain increases PDGF-B mRNA and PDGFB promoter activity (~12-fold) and PDGF-β receptor protein (~1.8-fold) in vascular smooth muscle cells; neutralizing antibodies to the PDGF-β receptor reduce strain-induced DNA synthesis by 50%, establishing PDGF-B as a mediator of mechanically induced VSMC proliferation.","method":"Cyclic strain apparatus, PDGFB-promoter-CAT reporter transfection, Northern blot, PDGF-β receptor protein immunoblot, neutralizing antibody inhibition of 3H-thymidine incorporation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — promoter-reporter and receptor antibody blockade mechanistically link mechanical strain to PDGF-B-dependent proliferation; single lab, multiple methods","pmids":["10558917"],"is_preprint":false}],"current_model":"PDGFB (c-sis) encodes the B chain of PDGF, which is synthesized as a precursor in the ER-Golgi (where signal cleavage and glycosylation occur), secreted as a disulfide-linked dimer, and acts by binding and activating the PDGF receptor tyrosine kinase at the cell surface to drive autocrine/paracrine mitogenic and chemotactic signaling; v-sis-driven transformation can additionally occur through intracellular (pre-surface) receptor activation; endothelial cell- and microglia-derived PDGFB recruits and maintains pericyte coverage (requiring ECM retention via a proteoglycan-binding motif) to sustain blood-brain barrier integrity and vascular stabilization; transcriptional regulation involves PKC, TGF-β, and mechanical strain via defined promoter elements (SPE); in tumors the COL1A1-PDGFB fusion places PDGFB under constitutive expression, generating an autocrine PDGFRβ loop driving dermatofibrosarcoma protuberans; and microglia-derived PDGFB additionally signals through neuronal PDGFRα to maintain Kv4.3-mediated potassium currents and suppress sympathetic tone."},"narrative":{"mechanistic_narrative":"PDGFB (c-sis) encodes the B chain of platelet-derived growth factor, a secreted disulfide-linked dimeric mitogen that signals through cell-surface PDGF receptor tyrosine kinases to drive proliferative and chemotactic responses [PMID:6329745, PMID:6091918]. The protein is matured through the ER-Golgi, where signal-sequence cleavage and N-linked glycosylation occur; it contains no transmembrane region, and proper signal-sequence-dependent trafficking is required for biological activity [PMID:3537701]. In its viral oncogene form (v-sis), the product transforms cells by binding and autophosphorylating the PDGF receptor and inducing DNA synthesis, with transformation strictly contingent on receptor presence in the target cell and reversible by selective PDGF-receptor kinase inhibitors [PMID:6091918, PMID:2996133, PMID:7954456]; this activating ligand-receptor interaction normally occurs at the plasma membrane, since blocking secretion or surface binding abolishes receptor autophosphorylation and c-fos induction, yet ER-retained, non-secreted mutants can also transform, demonstrating an additional intracellular autoactivation route [PMID:2455725, PMID:2551043]. Downstream, PDGF-B engages a Ras/Raf-dependent, PKC-independent cascade to induce immediate-early genes and activates a dedicated sis-inducible factor (SIF) acting on the c-fos promoter independently of the serum-responsive element [PMID:2176154, PMID:7890805]. Physiologically, PDGFB recruits and maintains mural-cell coverage of the vasculature: endothelial-, platelet-, microglia-, macrophage-, and lymphatic-endothelial-derived PDGFB directs pericyte and smooth-muscle-cell investment to stabilize blood vessels, with extracellular-matrix retention via its proteoglycan-binding motif essential for this recruitment [PMID:26599395, PMID:28851707, PMID:32586981, PMID:33591958]. Microglia are the principal source sustaining adult blood-brain-barrier integrity, and loss-of-function PDGFB mutations that prevent synthesis or PDGFRβ binding cause primary familial brain calcification [PMID:26599395, PMID:37992789]. PDGFB transcription is controlled by phorbol ester/PKC, TGF-β, mechanical strain, and defined factors acting on promoter elements including the SIS proximal element [PMID:2655888, PMID:8356057, PMID:10558917]. In dermatofibrosarcoma protuberans, a COL1A1-PDGFB fusion places PDGFB under constitutive COL1A1-driven expression, generating an autocrine PDGFRβ loop that confers tumorigenicity and is sensitive to imatinib [PMID:9739023, PMID:11420709, PMID:11291071].","teleology":[{"year":1984,"claim":"Establishing that the c-sis proto-oncogene encodes the PDGF B chain unified a transforming retroviral gene with a known mitogen, defining the molecular identity of PDGFB.","evidence":"Direct amino acid sequencing of purified PDGF B chain matched to c-sis genomic sequence","pmids":["6329745"],"confidence":"High","gaps":["Did not address how the secreted protein engages receptors or drives transformation","No information on physiological tissue source"]},{"year":1985,"claim":"Demonstrating that the v-sis product binds the PDGF receptor, stimulates receptor tyrosine phosphorylation, and requires receptor presence for transformation defined an autocrine surface-receptor mechanism for sis-driven growth.","evidence":"Receptor binding, tyrosine phosphorylation, and DNA-synthesis assays with antibody inhibition and receptor-positive vs -negative cells","pmids":["6091918","2996133"],"confidence":"High","gaps":["Did not resolve where activation occurs in the cell","Did not identify downstream effectors"]},{"year":1986,"claim":"Mapping the secretory processing route established that PDGFB matures through the ER-Golgi with signal cleavage and glycosylation and that correct trafficking is required for activity.","evidence":"Site-directed mutagenesis, microsome trypsin-protection, fractionation, immunofluorescence and transformation assays; membrane-anchored fusion analysis","pmids":["3537701","3536965"],"confidence":"High","gaps":["Did not define the proteoglycan-binding/ECM-retention function later shown to be essential","Membrane-anchored form work is single-lab Medium confidence"]},{"year":1988,"claim":"Pharmacological blockade of secretion and surface binding localized the active signaling event to the plasma membrane, testing whether autocrine activation is intracellular or extracellular.","evidence":"Inducible v-sis expression with monensin/suramin and receptor autophosphorylation/c-fos readouts","pmids":["2455725"],"confidence":"High","gaps":["Apparently contradicted by later ER-retention transformation data","Did not quantify relative contribution of surface vs internal routes"]},{"year":1989,"claim":"ER-retained, non-secreted v-sis mutants that still transform demonstrated an intracellular pre-surface receptor-activation route, qualifying the strict surface-only model.","evidence":"ER-retention signal mutagenesis, transformation assay, anti-PDGF antisera failing to reverse transformation","pmids":["2551043"],"confidence":"High","gaps":["Did not define the subcellular site of intracellular activation","Relevance of internal activation to non-viral PDGFB unclear"]},{"year":1990,"claim":"Identification of a sis-inducible factor and the SIF promoter element defined a PDGF-B-specific transcriptional output distinct from the serum-response pathway.","evidence":"Recombinant PDGF-B induction, gel-shift, and c-fos promoter-reporter deletion analysis","pmids":["2176154"],"confidence":"High","gaps":["Did not molecularly identify the SIF protein","Receptor-to-SIF signaling steps not defined"]},{"year":1994,"claim":"Genetic and pharmacological dissection placed PDGF-B signaling in a Ras/Raf-dependent, PKC-independent cascade and confirmed transformation runs specifically through PDGF-receptor kinase.","evidence":"Dominant-negative Ras/Raf in Egr-1 induction assays; selective tyrphostin reversion of sis-transformed cells with kinase-specificity profiling","pmids":["7890805","7954456"],"confidence":"High","gaps":["Did not map full downstream effector network","Egr-1 epistasis is single-lab Medium confidence"]},{"year":1993,"claim":"Promoter dissection showed phorbol ester/PKC-, TGF-β-, and strain-responsive elements—including the SIS proximal element—control PDGFB transcription, defining its inducible regulation.","evidence":"Nuclear run-on, linker-scanning/deletion promoter mutagenesis, reporter and gel-shift assays, cycloheximide blockade; 5'UTR translational control","pmids":["8356057","2655888","3466024","2740212"],"confidence":"High","gaps":["Identity of the SPE-binding factor not established","Mostly single-cell-type, single-lab analyses"]},{"year":1998,"claim":"Characterizing recurrent COL1A1-PDGFB fusions in DFSP showed how PDGFB is placed under constitutive COL1A1-promoter control with loss of its negative regulatory elements, linking PDGFB deregulation to a defined tumor.","evidence":"RT-PCR, sequencing, Southern blotting and breakpoint mapping across 16 DFSP/GCF tumors","pmids":["9739023"],"confidence":"Medium","gaps":["Processing/functional consequence of exon-2 retention not directly tested here","Did not demonstrate autocrine loop functionally"]},{"year":2001,"claim":"Reconstitution proved the COL1A1-PDGFB chimera is processed to active PDGFB dimers driving an autocrine PDGFRβ loop conferring tumorigenicity, and that imatinib reverses this transformed phenotype.","evidence":"Stable/transient transfection, antibody immunodetection, receptor-activation assays, nude-mouse tumorigenicity, cleavage-site mutagenesis; STI571 treatment with washout reversal in vitro and in vivo","pmids":["11420709","11291071"],"confidence":"High","gaps":["Imatinib effect is cytostatic and from a single lab","Contribution of uncleaved vs processed forms not fully quantified"]},{"year":2017,"claim":"Cell-type-specific deletion established that PDGFB recruits mural cells (pericytes, smooth muscle) and that its ECM-retention motif is required, defining the physiological vascular-stabilization function across vascular beds.","evidence":"LEC-specific Pdgfb conditional knockout, overexpression, ECM-retention mutant analysis, and vessel morphology/contraction phenotyping","pmids":["28851707"],"confidence":"High","gaps":["Did not address adult maintenance vs developmental roles","Mechanism of ECM-dependent local gradient formation not detailed"]},{"year":2019,"claim":"Loss-of-function mutation analysis and Pdgfbret/ret mice tied PDGFB to primary familial brain calcification and showed the tissue-retention function, not pericyte number alone, underlies the disease.","evidence":"In vitro receptor binding/autophosphorylation of patient mutants, knockout/knockin mouse models, pericyte and BBB readouts; glymphatic CSF-transport analysis","pmids":["26599395","30865886"],"confidence":"High","gaps":["Mechanism linking retention loss to calcification not fully resolved","Glymphatic findings are single-lab Medium confidence"]},{"year":2023,"claim":"Cell-source dissection in adults revealed microglia—not endothelium—as the principal PDGFB source maintaining the adult blood-brain barrier, distinguishing developmental from maintenance functions.","evidence":"Transcriptomics/in situ source identification, acute microglial vs endothelial and adult vs neonatal conditional knockouts, BBB integrity and endotoxin-challenge survival; tamoxifen-inducible endothelial knockout comparison with constitutive loss; macrophage- and platelet-derived sources in pulmonary hypertension and tumor metastasis","pmids":["37992789","34689641","32586981","33591958"],"confidence":"High","gaps":["How distinct cellular sources are coordinated in vivo not resolved","Signals triggering microglial PDGFB upregulation incompletely defined"]},{"year":2021,"claim":"Identifying a microglia→neuronal PDGFRα axis controlling Kv4.3 currents extended PDGFB function beyond mitogenesis to neuronal excitability and blood-pressure control.","evidence":"Microglial ablation, LysM-Cre Pdgfb knockout, neuronal PDGFRα knockdown, electrophysiology, blood pressure measurement, exogenous PDGFB rescue","pmids":["35863346"],"confidence":"High","gaps":["Molecular link between PDGFRα signaling and Kv4.3 expression not defined","Single-system finding"]},{"year":2023,"claim":"Mapping upstream transcriptional regulators (SDF-1α/ELK-1, E2F1/VEGFR-3, C/EBPβ, PROX1/FOXC2, TIE2/AKT) placed PDGFB within multiple disease-relevant regulatory circuits.","evidence":"ChIP, promoter-reporter, knockdown/overexpression, conditional knockouts, pharmacological rescue, and human tissue validation across pericyte differentiation, vascular malformation, valve degeneration, and cancer contexts","pmids":["21911740","24014887","34341514","37555328","23633549"],"confidence":"High","gaps":["Cross-talk among these regulators not integrated","Several individual circuits are single-lab Medium confidence"]},{"year":null,"claim":"How PDGFB integrates its multiple cellular sources, ECM-dependent local retention, and receptor choice (PDGFRβ on mural cells vs PDGFRα on neurons) into context-specific outputs remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of source-specific PDGFB function in vivo","Molecular determinant selecting PDGFRα vs PDGFRβ engagement unknown","Identity of the SPE/SIF transcription and signaling proteins not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[0,1,2,19]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,2,5,12]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[3,6]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[3,4]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,5,20]},{"term_id":"GO:0031012","term_label":"extracellular matrix","supporting_discovery_ids":[19,20]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4,5]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,9,21]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[19,20,26]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,14,19,25]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[8,11,17,28,29,30]}],"complexes":[],"partners":["PDGFRB","PDGFRA"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P01127","full_name":"Platelet-derived growth factor subunit B","aliases":["PDGF-2","Platelet-derived growth factor B chain","Platelet-derived growth factor beta polypeptide","Proto-oncogene c-Sis"],"length_aa":241,"mass_kda":27.3,"function":"Growth factor that plays an essential role in the regulation of embryonic development, cell proliferation, cell migration, survival and chemotaxis. Potent mitogen for cells of mesenchymal origin (PubMed:26599395). Required for normal proliferation and recruitment of pericytes and vascular smooth muscle cells in the central nervous system, skin, lung, heart and placenta. Required for normal blood vessel development, and for normal development of kidney glomeruli. Plays an important role in wound healing. Signaling is modulated by the formation of heterodimers with PDGFA (By similarity)","subcellular_location":"Secreted","url":"https://www.uniprot.org/uniprotkb/P01127/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PDGFB","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PDGFB","total_profiled":1310},"omim":[{"mim_id":"619206","title":"SCHWANNOMIN-INTERACTING PROTEIN 1; SCHIP1","url":"https://www.omim.org/entry/619206"},{"mim_id":"617492","title":"OLFACTOMEDIN 2; OLFM2","url":"https://www.omim.org/entry/617492"},{"mim_id":"615483","title":"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5","url":"https://www.omim.org/entry/615483"},{"mim_id":"615007","title":"BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4","url":"https://www.omim.org/entry/615007"},{"mim_id":"612139","title":"PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE-DEPENDENT RAC EXCHANGER 2; PREX2","url":"https://www.omim.org/entry/612139"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PDGFB"},"hgnc":{"alias_symbol":["SSV"],"prev_symbol":["SIS"]},"alphafold":{"accession":"P01127","domains":[{"cath_id":"2.10.90.10","chopping":"97-181","consensus_level":"high","plddt":94.7028,"start":97,"end":181}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P01127","model_url":"https://alphafold.ebi.ac.uk/files/AF-P01127-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P01127-F1-predicted_aligned_error_v6.png","plddt_mean":73.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PDGFB","jax_strain_url":"https://www.jax.org/strain/search?query=PDGFB"},"sequence":{"accession":"P01127","fasta_url":"https://rest.uniprot.org/uniprotkb/P01127.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P01127/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P01127"}},"corpus_meta":[{"pmid":"12682500","id":"PMC_12682500","title":"2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.","date":"2003","source":"Critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12682500","citation_count":4335,"is_preprint":false},{"pmid":"12664219","id":"PMC_12664219","title":"2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.","date":"2003","source":"Intensive care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/12664219","citation_count":1678,"is_preprint":false},{"pmid":"2176154","id":"PMC_2176154","title":"The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter.","date":"1990","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/2176154","citation_count":595,"is_preprint":false},{"pmid":"6329745","id":"PMC_6329745","title":"The c-sis gene encodes a precursor of the B chain of platelet-derived growth factor.","date":"1984","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/6329745","citation_count":355,"is_preprint":false},{"pmid":"6091918","id":"PMC_6091918","title":"Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors.","date":"1984","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/6091918","citation_count":267,"is_preprint":false},{"pmid":"7954456","id":"PMC_7954456","title":"Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.","date":"1994","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/7954456","citation_count":249,"is_preprint":false},{"pmid":"6208557","id":"PMC_6208557","title":"Expression of the sis gene by endothelial cells in culture and in vivo.","date":"1984","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/6208557","citation_count":230,"is_preprint":false},{"pmid":"16842882","id":"PMC_16842882","title":"Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice.","date":"2006","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/16842882","citation_count":206,"is_preprint":false},{"pmid":"2551043","id":"PMC_2551043","title":"Transformation by v-sis occurs by an internal autoactivation mechanism.","date":"1989","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2551043","citation_count":184,"is_preprint":false},{"pmid":"2996133","id":"PMC_2996133","title":"Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor.","date":"1985","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2996133","citation_count":132,"is_preprint":false},{"pmid":"9739023","id":"PMC_9739023","title":"Various regions within the alpha-helical domain of the COL1A1 gene are fused to the second exon of the PDGFB gene in dermatofibrosarcomas and giant-cell fibroblastomas.","date":"1998","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9739023","citation_count":128,"is_preprint":false},{"pmid":"30865886","id":"PMC_30865886","title":"PDGF-B Is Required for Development of the Glymphatic System.","date":"2019","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/30865886","citation_count":116,"is_preprint":false},{"pmid":"3466024","id":"PMC_3466024","title":"Phorbol ester induces c-sis gene transcription in stem cell line K-562.","date":"1986","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3466024","citation_count":116,"is_preprint":false},{"pmid":"27816607","id":"PMC_27816607","title":"PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice.","date":"2016","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/27816607","citation_count":96,"is_preprint":false},{"pmid":"23633549","id":"PMC_23633549","title":"Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB.","date":"2013","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23633549","citation_count":91,"is_preprint":false},{"pmid":"24273692","id":"PMC_24273692","title":"Biochemical and biomechanical characterization of porcine small intestinal submucosa (SIS): a mini review.","date":"2013","source":"International journal of burns and trauma","url":"https://pubmed.ncbi.nlm.nih.gov/24273692","citation_count":88,"is_preprint":false},{"pmid":"11291071","id":"PMC_11291071","title":"Growth-inhibitory effect of STI571 on cells transformed by the COL1A1/PDGFB rearrangement.","date":"2001","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/11291071","citation_count":88,"is_preprint":false},{"pmid":"26129893","id":"PMC_26129893","title":"Brain calcification process and phenotypes according to age and sex: Lessons from SLC20A2, PDGFB, and PDGFRB mutation carriers.","date":"2015","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26129893","citation_count":86,"is_preprint":false},{"pmid":"34341514","id":"PMC_34341514","title":"Anoikis resistant gastric cancer cells promote angiogenesis and peritoneal metastasis through C/EBPβ-mediated PDGFB autocrine and paracrine signaling.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/34341514","citation_count":83,"is_preprint":false},{"pmid":"26599395","id":"PMC_26599395","title":"Functional Characterization of Germline Mutations in PDGFB and PDGFRB in Primary Familial Brain Calcification.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26599395","citation_count":82,"is_preprint":false},{"pmid":"14755687","id":"PMC_14755687","title":"Angiopoietin 1, PDGF-B, and TGF-beta gene regulation in endothelial cell and smooth muscle cell interaction.","date":"2004","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14755687","citation_count":81,"is_preprint":false},{"pmid":"11420709","id":"PMC_11420709","title":"Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP).","date":"2001","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/11420709","citation_count":77,"is_preprint":false},{"pmid":"32586981","id":"PMC_32586981","title":"Platelet-Specific PDGFB Ablation Impairs Tumor Vessel Integrity and Promotes Metastasis.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32586981","citation_count":72,"is_preprint":false},{"pmid":"12566156","id":"PMC_12566156","title":"Cryopreservation of goat oocytes and in vivo derived 2- to 4-cell embryos using the cryoloop (CLV) and solid-surface vitrification (SSV) methods.","date":"2003","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/12566156","citation_count":69,"is_preprint":false},{"pmid":"29955147","id":"PMC_29955147","title":"Alternative PDGFD rearrangements in dermatofibrosarcomas protuberans without PDGFB fusions.","date":"2018","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/29955147","citation_count":68,"is_preprint":false},{"pmid":"32194815","id":"PMC_32194815","title":"An intestinal model with a finger-like villus structure fabricated using a bioprinting process and collagen/SIS-based cell-laden bioink.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32194815","citation_count":65,"is_preprint":false},{"pmid":"2455725","id":"PMC_2455725","title":"Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface.","date":"1988","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/2455725","citation_count":63,"is_preprint":false},{"pmid":"20624165","id":"PMC_20624165","title":"Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma.","date":"2010","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/20624165","citation_count":61,"is_preprint":false},{"pmid":"16980946","id":"PMC_16980946","title":"Gains of COL1A1-PDGFB genomic copies occur in fibrosarcomatous transformation of dermatofibrosarcoma protuberans.","date":"2006","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/16980946","citation_count":61,"is_preprint":false},{"pmid":"30335555","id":"PMC_30335555","title":"SIS-ECM Laden with GMSC-Derived Exosomes Promote Taste Bud Regeneration.","date":"2018","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/30335555","citation_count":59,"is_preprint":false},{"pmid":"33591958","id":"PMC_33591958","title":"Macrophage-derived PDGF-B induces muscularization in murine and human pulmonary hypertension.","date":"2021","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/33591958","citation_count":59,"is_preprint":false},{"pmid":"2983195","id":"PMC_2983195","title":"Translocation of oncogene c-sis from chromosome 22 to chromosome 11 in a Ewing sarcoma-derived cell line.","date":"1985","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/2983195","citation_count":59,"is_preprint":false},{"pmid":"24014887","id":"PMC_24014887","title":"E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B.","date":"2013","source":"Journal of molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/24014887","citation_count":58,"is_preprint":false},{"pmid":"17431412","id":"PMC_17431412","title":"Detection of COL1A1-PDGFB fusion transcripts and PDGFB/PDGFRB mRNA expression in dermatofibrosarcoma protuberans.","date":"2007","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/17431412","citation_count":56,"is_preprint":false},{"pmid":"28851707","id":"PMC_28851707","title":"Smooth muscle cell recruitment to lymphatic vessels requires PDGFB and impacts vessel size but not identity.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28851707","citation_count":55,"is_preprint":false},{"pmid":"26150503","id":"PMC_26150503","title":"PDGFB-based stem cell gene therapy increases bone strength in the mouse.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26150503","citation_count":54,"is_preprint":false},{"pmid":"24423492","id":"PMC_24423492","title":"LIM-homeobox gene 2 promotes tumor growth and metastasis by inducing autocrine and paracrine PDGF-B signaling.","date":"2013","source":"Molecular oncology","url":"https://pubmed.ncbi.nlm.nih.gov/24423492","citation_count":54,"is_preprint":false},{"pmid":"35863346","id":"PMC_35863346","title":"Microglia-derived PDGFB promotes neuronal potassium currents to suppress basal sympathetic tonicity and limit hypertension.","date":"2022","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/35863346","citation_count":51,"is_preprint":false},{"pmid":"24604296","id":"PMC_24604296","title":"PDGFB partial deletion: a new, rare mechanism causing brain calcification with leukoencephalopathy.","date":"2014","source":"Journal of molecular neuroscience : MN","url":"https://pubmed.ncbi.nlm.nih.gov/24604296","citation_count":50,"is_preprint":false},{"pmid":"34689641","id":"PMC_34689641","title":"Adult-induced genetic ablation distinguishes PDGFB roles in blood-brain barrier maintenance and development.","date":"2021","source":"Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34689641","citation_count":47,"is_preprint":false},{"pmid":"24518837","id":"PMC_24518837","title":"A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia.","date":"2014","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/24518837","citation_count":44,"is_preprint":false},{"pmid":"10558917","id":"PMC_10558917","title":"Mechanical strain increases PDGF-B and PDGF beta receptor expression in vascular smooth muscle cells.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10558917","citation_count":44,"is_preprint":false},{"pmid":"2182793","id":"PMC_2182793","title":"Enhanced expression of the sis and c-myc oncogenes in human meningiomas.","date":"1990","source":"Journal of neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/2182793","citation_count":43,"is_preprint":false},{"pmid":"29955127","id":"PMC_29955127","title":"Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats.","date":"2018","source":"Gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/29955127","citation_count":42,"is_preprint":false},{"pmid":"30609140","id":"PMC_30609140","title":"Spectrum of SLC20A2, PDGFRB, PDGFB, and XPR1 mutations in a large cohort of patients with primary familial brain calcification.","date":"2019","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/30609140","citation_count":41,"is_preprint":false},{"pmid":"7623836","id":"PMC_7623836","title":"scute (sis-b) function in Drosophila sex determination.","date":"1995","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/7623836","citation_count":41,"is_preprint":false},{"pmid":"16093451","id":"PMC_16093451","title":"Y-box protein 1 mediates PDGF-B effects in mesangioproliferative glomerular disease.","date":"2005","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/16093451","citation_count":40,"is_preprint":false},{"pmid":"19734356","id":"PMC_19734356","title":"VEGF-C regulates lymphangiogenesis and capillary stability by regulation of PDGF-B.","date":"2009","source":"American journal of physiology. Heart and circulatory physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19734356","citation_count":40,"is_preprint":false},{"pmid":"10815761","id":"PMC_10815761","title":"Effects of H-ras and v-sis overexpression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells.","date":"2000","source":"Journal of cancer research and clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/10815761","citation_count":40,"is_preprint":false},{"pmid":"2740212","id":"PMC_2740212","title":"Regulation of expression of the c-sis proto-oncogene.","date":"1989","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/2740212","citation_count":40,"is_preprint":false},{"pmid":"2655888","id":"PMC_2655888","title":"Control of the expression of c-sis mRNA in human glioblastoma cells by phorbol ester and transforming growth factor beta 1.","date":"1989","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/2655888","citation_count":39,"is_preprint":false},{"pmid":"3456250","id":"PMC_3456250","title":"C-sis and C-abl expression in chronic myelogenous leukemia and other hematologic malignancies.","date":"1986","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/3456250","citation_count":38,"is_preprint":false},{"pmid":"19249357","id":"PMC_19249357","title":"Short-term plasticity of small synaptic vesicle (SSV) and large dense-core vesicle (LDCV) exocytosis.","date":"2009","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/19249357","citation_count":37,"is_preprint":false},{"pmid":"24023893","id":"PMC_24023893","title":"Lrig2-deficient mice are protected against PDGFB-induced glioma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24023893","citation_count":37,"is_preprint":false},{"pmid":"3177660","id":"PMC_3177660","title":"Kidney epithelial cells express c-sis protooncogene and secrete PDGF-like protein.","date":"1988","source":"The American journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/3177660","citation_count":35,"is_preprint":false},{"pmid":"30706473","id":"PMC_30706473","title":"SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K/AKT/PDGFB/PDGFRβ axis.","date":"2019","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30706473","citation_count":33,"is_preprint":false},{"pmid":"11329146","id":"PMC_11329146","title":"Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.","date":"2001","source":"The Journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/11329146","citation_count":32,"is_preprint":false},{"pmid":"2105102","id":"PMC_2105102","title":"Induction of fos and sis proto-oncogenes and genes of the extracellular matrix proteins during butyrate induced glioma differentiation.","date":"1990","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/2105102","citation_count":32,"is_preprint":false},{"pmid":"21911740","id":"PMC_21911740","title":"SDF-1α induces PDGF-B expression and the differentiation of bone marrow cells into pericytes.","date":"2011","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/21911740","citation_count":31,"is_preprint":false},{"pmid":"3052584","id":"PMC_3052584","title":"Expression and stability of c-sis mRNA in human glioblastoma cells.","date":"1988","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/3052584","citation_count":30,"is_preprint":false},{"pmid":"8356057","id":"PMC_8356057","title":"Identification and characterization of an essential, activating regulatory element of the human SIS/PDGFB promoter in human megakaryocytes.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8356057","citation_count":30,"is_preprint":false},{"pmid":"33935795","id":"PMC_33935795","title":"M2 Macrophages Promote PDGFRβ+ Pericytes Migration After Spinal Cord Injury in Mice via PDGFB/PDGFRβ Pathway.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33935795","citation_count":30,"is_preprint":false},{"pmid":"32371931","id":"PMC_32371931","title":"Endothelial Twist1-PDGFB signaling mediates hypoxia-induced proliferation and migration of αSMA-positive cells.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32371931","citation_count":29,"is_preprint":false},{"pmid":"25819339","id":"PMC_25819339","title":"PDGF-D signaling in portal myofibroblasts and hepatic stellate cells proves identical to PDGF-B via both PDGF receptor type α and β.","date":"2015","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25819339","citation_count":29,"is_preprint":false},{"pmid":"35454853","id":"PMC_35454853","title":"Platelet-Derived PDGFB Promotes Recruitment of Cancer-Associated Fibroblasts, Deposition of Extracellular Matrix and Tgfβ Signaling in the Tumor Microenvironment.","date":"2022","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/35454853","citation_count":28,"is_preprint":false},{"pmid":"32165827","id":"PMC_32165827","title":"MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells.","date":"2020","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/32165827","citation_count":27,"is_preprint":false},{"pmid":"9790508","id":"PMC_9790508","title":"COL1A1-PDGFB fusion in a ring chromosome 4 found in a dermatofibrosarcoma protuberans.","date":"1998","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9790508","citation_count":27,"is_preprint":false},{"pmid":"33145744","id":"PMC_33145744","title":"Effect of PDGF-B Gene-Activated Acellular Matrix and Mesenchymal Stem Cell Transplantation on Full Thickness Skin Burn Wound in Rat Model.","date":"2020","source":"Tissue engineering and regenerative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33145744","citation_count":27,"is_preprint":false},{"pmid":"3536965","id":"PMC_3536965","title":"Cell surface expression of membrane-anchored v-sis gene products: glycosylation is not required for cell surface transport.","date":"1986","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/3536965","citation_count":27,"is_preprint":false},{"pmid":"3537701","id":"PMC_3537701","title":"Biosynthesis of the v-sis gene product: signal sequence cleavage, glycosylation, and proteolytic processing.","date":"1986","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/3537701","citation_count":26,"is_preprint":false},{"pmid":"31804621","id":"PMC_31804621","title":"PDGFB-expressing mesenchymal stem cells improve human hematopoietic stem cell engraftment in immunodeficient mice.","date":"2019","source":"Bone marrow transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/31804621","citation_count":25,"is_preprint":false},{"pmid":"29738888","id":"PMC_29738888","title":"Effect of PDGF-B aptamer on PDGFRβ/PDGF-B interaction: Molecular dynamics study.","date":"2018","source":"Journal of molecular graphics & modelling","url":"https://pubmed.ncbi.nlm.nih.gov/29738888","citation_count":25,"is_preprint":false},{"pmid":"36848483","id":"PMC_36848483","title":"New Insights into Baicalein's Effect on Chlorpyrifos-Induced Liver Injury in Carp: Involving Macrophage Polarization and Pyropto sis.","date":"2023","source":"Journal of agricultural and food chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/36848483","citation_count":25,"is_preprint":false},{"pmid":"16014047","id":"PMC_16014047","title":"Hypoxia regulates PDGF-B interactions between glomerular capillary endothelial and mesangial cells.","date":"2005","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16014047","citation_count":24,"is_preprint":false},{"pmid":"17724602","id":"PMC_17724602","title":"Induction of PDGF-B in TCA-treated epidermal keratinocytes.","date":"2007","source":"Archives of dermatological research","url":"https://pubmed.ncbi.nlm.nih.gov/17724602","citation_count":23,"is_preprint":false},{"pmid":"23347652","id":"PMC_23347652","title":"PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.","date":"2013","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/23347652","citation_count":22,"is_preprint":false},{"pmid":"3003695","id":"PMC_3003695","title":"Structure and nucleotide sequence of the 5' region of the human and feline c-sis proto-oncogenes.","date":"1986","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/3003695","citation_count":22,"is_preprint":false},{"pmid":"33846539","id":"PMC_33846539","title":"MicroRNA-432-5p regulates sprouting and intussusceptive angiogenesis in osteosarcoma microenvironment by targeting PDGFB.","date":"2021","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33846539","citation_count":21,"is_preprint":false},{"pmid":"35672821","id":"PMC_35672821","title":"PDGFB targeting biodegradable FePt alloy assembly for MRI guided starvation-enhancing chemodynamic therapy of cancer.","date":"2022","source":"Journal of nanobiotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/35672821","citation_count":21,"is_preprint":false},{"pmid":"31446049","id":"PMC_31446049","title":"SIS/aligned fibre scaffold designed to meet layered oesophageal tissue complexity and properties.","date":"2019","source":"Acta biomaterialia","url":"https://pubmed.ncbi.nlm.nih.gov/31446049","citation_count":20,"is_preprint":false},{"pmid":"8177392","id":"PMC_8177392","title":"Specific inhibition of c-sis protein synthesis and cell proliferation with antisense oligodeoxynucleotides in human glioma cells.","date":"1994","source":"Neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/8177392","citation_count":20,"is_preprint":false},{"pmid":"33762682","id":"PMC_33762682","title":"PDGFB RNA in situ hybridization for the diagnosis of dermatofibrosarcoma protuberans.","date":"2021","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/33762682","citation_count":19,"is_preprint":false},{"pmid":"2152993","id":"PMC_2152993","title":"S71 is a phylogenetically distinct human endogenous retroviral element with structural and sequence homology to simian sarcoma virus (SSV).","date":"1990","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/2152993","citation_count":19,"is_preprint":false},{"pmid":"37992789","id":"PMC_37992789","title":"An integral blood-brain barrier in adulthood relies on microglia-derived PDGFB.","date":"2023","source":"Brain, behavior, and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/37992789","citation_count":18,"is_preprint":false},{"pmid":"17367764","id":"PMC_17367764","title":"Study of biocompatibility of small intestinal submucosa (SIS) with Schwann cells in vitro.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17367764","citation_count":18,"is_preprint":false},{"pmid":"2824537","id":"PMC_2824537","title":"Platelet-derived growth factor/sis in normal and neoplastic cell growth.","date":"1987","source":"Journal of cellular physiology. Supplement","url":"https://pubmed.ncbi.nlm.nih.gov/2824537","citation_count":17,"is_preprint":false},{"pmid":"36203755","id":"PMC_36203755","title":"Endothelial senescence mediates hypoxia-induced vascular remodeling by modulating PDGFB expression.","date":"2022","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36203755","citation_count":17,"is_preprint":false},{"pmid":"31870844","id":"PMC_31870844","title":"Genomic and transcriptomic features of dermatofibrosarcoma protuberans: Unusual chromosomal origin of the COL1A1-PDGFB fusion gene and synergistic effects of amplified regions in tumor development.","date":"2019","source":"Cancer genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31870844","citation_count":17,"is_preprint":false},{"pmid":"30480452","id":"PMC_30480452","title":"200+ Protein Concentrations in Healthy Human Blood Plasma: Targeted Quantitative SRM SIS Screening of Chromosomes 18, 13, Y, and the Mitochondrial Chromosome Encoded Proteome.","date":"2018","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/30480452","citation_count":17,"is_preprint":false},{"pmid":"33520084","id":"PMC_33520084","title":"Overexpression of MiR-29b-3p Inhibits Atrial Remodeling in Rats by Targeting PDGF-B Signaling Pathway.","date":"2021","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/33520084","citation_count":17,"is_preprint":false},{"pmid":"37555328","id":"PMC_37555328","title":"PROX1 Inhibits PDGF-B Expression to Prevent Myxomatous Degeneration of Heart Valves.","date":"2023","source":"Circulation research","url":"https://pubmed.ncbi.nlm.nih.gov/37555328","citation_count":16,"is_preprint":false},{"pmid":"35793004","id":"PMC_35793004","title":"Intratumoral PDGFB gene predominantly expressed in endothelial cells is associated with angiogenesis and lymphangiogenesis, but not with metastasis in breast cancer.","date":"2022","source":"Breast cancer research and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/35793004","citation_count":16,"is_preprint":false},{"pmid":"198378","id":"PMC_198378","title":"Establishment of simian sarcoma virus, type 1 (SSV-1)-transformed non-producer marmoset cell lines.","date":"1977","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/198378","citation_count":16,"is_preprint":false},{"pmid":"16110514","id":"PMC_16110514","title":"The effect of equilibration time on survival and development rates of mouse pronuclear-stage embryos vitrified in solid surface (SSV) and convential straws: in vitro and in vivo evaluations.","date":"2005","source":"Molecular reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/16110514","citation_count":15,"is_preprint":false},{"pmid":"1353485","id":"PMC_1353485","title":"Expression of c-sis and c-fos genes in human meningiomas and neurinomas.","date":"1992","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/1353485","citation_count":15,"is_preprint":false},{"pmid":"2793239","id":"PMC_2793239","title":"Expression of c-sis and other cellular proto-oncogenes in human sarcoma cell lines and biopsies.","date":"1989","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/2793239","citation_count":15,"is_preprint":false},{"pmid":"36030617","id":"PMC_36030617","title":"SB431542 alleviates lupus nephritis by regulating B cells and inhibiting the TLR9/TGFβ1/PDGFB signaling.","date":"2022","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/36030617","citation_count":14,"is_preprint":false},{"pmid":"7890805","id":"PMC_7890805","title":"V-sis induces Egr-1 expression by a pathway mediated by c-Ha-Ras.","date":"1994","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7890805","citation_count":14,"is_preprint":false},{"pmid":"35459473","id":"PMC_35459473","title":"Diverse roles of tumor-stromal PDGFB-to-PDGFRβ signaling in breast cancer growth and metastasis.","date":"2022","source":"Advances in cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35459473","citation_count":13,"is_preprint":false},{"pmid":"2824043","id":"PMC_2824043","title":"Platelet-derived growth factor: roles in normal and v-sis transformed cells.","date":"1985","source":"Cancer surveys","url":"https://pubmed.ncbi.nlm.nih.gov/2824043","citation_count":13,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52214,"output_tokens":8978,"usd":0.145656,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18911,"output_tokens":5262,"usd":0.113053,"stage2_stop_reason":"end_turn"},"total_usd":0.258709,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1984,\n      \"finding\": \"The c-sis proto-oncogene encodes a precursor of the B chain of platelet-derived growth factor (PDGF-B), as established by amino acid sequence identity between PDGF B chain and the predicted protein from c-sis genomic sequences over 109 residues.\",\n      \"method\": \"Amino acid sequence analysis of purified PDGF B chain combined with nucleotide sequence analysis of c-sis genomic clones\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct protein sequencing matched to gene sequence; foundational finding independently consistent with multiple subsequent studies\",\n      \"pmids\": [\"6329745\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1984,\n      \"finding\": \"SSV-transformed cells secrete a PDGF-like protein (p28v-sis or its processed product) that stimulates autocrine cell growth through cell-surface PDGF receptors; anti-PDGF antisera block DNA synthesis in growing SSV-transformed cells and SSV-transformed cells have reduced numbers of high-affinity PDGF receptors; purified PDGF receptor from SSV cells retains active protein tyrosine kinase activity stimulated by PDGF.\",\n      \"method\": \"Mitogenic assays, 125I-PDGF receptor competition binding, anti-PDGF antisera inhibition of 3H-thymidine incorporation, receptor purification with tyrosine kinase activity assay\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal functional assays; receptor purification with biochemical activity confirmed; replicated conceptually across multiple studies\",\n      \"pmids\": [\"6091918\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1985,\n      \"finding\": \"The v-sis gene product transforms cells by binding to PDGF receptors, stimulating tyrosine phosphorylation of PDGF receptors, and inducing DNA synthesis; transformation susceptibility strictly correlates with the presence of PDGF receptors on the target cell; antibodies to different regions of the v-sis product specifically inhibit each of these activities.\",\n      \"method\": \"Partial purification of v-sis protein, PDGF receptor binding assay, tyrosine phosphorylation assay, DNA synthesis induction, antibody inhibition, viral infection of receptor-positive vs. receptor-negative cell types\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal biochemical assays with antibody-based functional inhibition; receptor requirement demonstrated by cell-type correlation\",\n      \"pmids\": [\"2996133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"The v-sis gene product is processed through the endoplasmic reticulum-Golgi compartment where signal sequence cleavage and N-linked glycosylation occur; the protein contains no transmembrane regions (fully protected from trypsin within microsomes); site-directed mutagenesis of the signal sequence produces proteins with nuclear mislocalization and loss of biological activity; mutagenesis of the proteolytic processing site (Lys-Arg 110-111 to Asn-Ser) retains full biological activity.\",\n      \"method\": \"Site-directed mutagenesis, intracellular fractionation, trypsin protection assay of isolated microsomes, indirect immunofluorescence, biological transformation assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis combined with subcellular fractionation and functional assay; single lab but multiple orthogonal methods\",\n      \"pmids\": [\"3537701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"Transmembrane (membrane-anchored) forms of the v-sis gene product are transported to the cell surface, dimerize, are glycosylated, and undergo NH2-terminal proteolytic processing; removal of the N-linked glycosylation site does not prevent cell surface transport; membrane-anchored mutants retain focus-forming (transforming) activity.\",\n      \"method\": \"Gene fusion construction, indirect immunofluorescence, focus formation assay, N-glycosylation site mutagenesis\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct localization by immunofluorescence linked to functional transformation assay; single lab, multiple methods\",\n      \"pmids\": [\"3536965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"Autocrine stimulation by v-sis (PDGF-B-related protein) requires a ligand-receptor interaction at the cell surface: monensin (blocking secretory transport) and suramin (blocking cell-surface receptor binding) each prevent PDGF receptor autophosphorylation and c-fos induction triggered by v-sis expression, indicating the active signaling event occurs at the plasma membrane rather than intracellularly.\",\n      \"method\": \"Inducible v-sis expression (heat-shock promoter), PDGF receptor autophosphorylation assay, c-fos induction assay, monensin and suramin pharmacological inhibition\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — two independent pharmacological interventions each blocking downstream readouts; inducible expression system with defined temporal control\",\n      \"pmids\": [\"2455725\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Transformation by v-sis occurs through an internal autoactivation mechanism: a v-sis mutant targeted for retention in the ER/Golgi (non-secreted) transforms NRK cells as efficiently as wild-type v-sis, and anti-PDGF antisera do not reverse transformation of SSV-NRK cells, demonstrating that intracellular (pre-surface) activation of the PDGF receptor is sufficient for transformation.\",\n      \"method\": \"ER-retention signal mutagenesis of v-sis, focus formation/transformation assay, anti-PDGF antisera treatment of transformed cells, secretion assay\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — genetic engineering of targeting signal, functional transformation assay, antibody blockade negative control; contradicts the pure autocrine surface model\",\n      \"pmids\": [\"2551043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"The 5' untranslated region of c-sis mRNA (1028 nt) contains sequences that inhibit protein synthesis; deletion of nucleotides 154-378 or 398-475 relieves this inhibition; sequences within 375 nt upstream of the RNA initiation site control transcriptional activity, and a transcriptional enhancer within this region is orientation-independent and responds to the HTLV-I transactivator protein.\",\n      \"method\": \"Deletion mutagenesis of 5'UTR in translation assays, CAT reporter gene transcriptional assays, HTLV-I transactivator co-transfection\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro functional assays with deletion mutants; single lab, mechanistic but not independently replicated\",\n      \"pmids\": [\"2740212\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"c-sis mRNA expression in glioblastoma cells is induced by phorbol ester (PMA) and TGF-β1 via transcriptional mechanisms (confirmed by nuclear run-on); PMA induction is protein-kinase C (PKC)-dependent while TGF-β1 induction is PKC-independent; both pathways are blocked by the protein kinase inhibitor H7, implicating a non-PKC kinase in TGF-β1 signaling to c-sis.\",\n      \"method\": \"Nuclear run-on transcription assay, PKC down-regulation, cycloheximide treatment, kinase inhibitors (H7), RNA-RNA solution hybridization\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — nuclear run-on confirms transcriptional mechanism; pharmacological pathway dissection with multiple agents; single lab\",\n      \"pmids\": [\"2655888\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1990,\n      \"finding\": \"PDGF-B/sis induces a DNA-binding protein (SIF, sis-inducible factor) that binds a conserved element (SIF binding element, ~-100 to -57 of c-fos) and confers PDGF-B-specific transcriptional inducibility on the c-fos promoter; this element functions independently of the serum-responsive element (SRE) and responds only to sis/PDGF (not to serum or phorbol esters); SRE and SIF elements act additively.\",\n      \"method\": \"Conditioned medium and recombinant PDGF-B induction, gel mobility-shift/DNA binding assays, oligonucleotide competition, promoter-reporter transfection with deletion/mutation analysis\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — recombinant PDGF-B used; DNA-protein interaction combined with functional promoter assay; multiple orthogonal methods in one study\",\n      \"pmids\": [\"2176154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1986,\n      \"finding\": \"Phorbol ester (TPA) induces c-sis transcription in the K-562 hematopoietic stem cell line (megakaryoblastic differentiation), as demonstrated by nuclear run-off transcriptional assay; this induction is not a general effect of TPA on hematopoietic cells.\",\n      \"method\": \"Northern blot analysis, nuclear run-off transcriptional assay, TPA treatment of multiple hematopoietic cell lines\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — nuclear run-off confirms transcriptional induction; single lab, single cell-type focus\",\n      \"pmids\": [\"3466024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"A 10-bp element (SIS proximal element, SPE) at positions -58 to -39 relative to the PDGFB mRNA initiation site is essential for TPA-induced transcriptional activation of PDGFB in megakaryocytes; TPA treatment induces formation of a new nuclear protein complex on the SPE that coincides temporally with endogenous PDGFB mRNA induction; both are blocked by cycloheximide, indicating a requirement for new protein synthesis.\",\n      \"method\": \"Linker-scanning mutagenesis of PDGFB promoter, luciferase reporter assay, gel mobility-shift assay with K562 nuclear extracts, cycloheximide inhibition, TPA induction time course\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — systematic mutagenesis across the promoter combined with protein-DNA binding and functional reporter assay; multiple orthogonal methods\",\n      \"pmids\": [\"8356057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"Selective PDGF receptor kinase inhibitors (tyrphostins AG1295 and AG1296) reverse the transformed phenotype of sis-transfected NIH 3T3 cells but have no effect on src-transformed cells, confirming that sis-driven transformation is mediated specifically through PDGF receptor kinase activity.\",\n      \"method\": \"Tyrphostin treatment of sis-transfected NIH 3T3 cells (phenotypic reversion assay), autophosphorylation assays for PDGF-Rα/β, KDR, and c-Src, DNA synthesis assays\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — selective pharmacological inhibitors with parallel positive (src) and negative (PDGFR) controls; receptor specificity profiled across multiple kinases\",\n      \"pmids\": [\"7954456\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"In dermatofibrosarcoma protuberans (DFSP) and giant-cell fibroblastomas, COL1A1-PDGFB chimeric genes always include exon 2 of PDGFB fused to varying exons of COL1A1's alpha-helical domain, placing PDGFB under the COL1A1 promoter and removing negative regulatory elements of PDGFB; retention of exon 2 in all fusions suggests it is required for normal PDGFB polypeptide processing.\",\n      \"method\": \"RT-PCR and DNA sequence analysis of chimeric transcripts from 16 DFSP/GCF tumors, Southern blotting, breakpoint mapping\",\n      \"journal\": \"Genes, chromosomes & cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — molecular characterization across 16 tumors; consistent fusion architecture implies functional constraint on exon 2 retention, but mechanism of processing not directly tested\",\n      \"pmids\": [\"9739023\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The COL1A1-PDGFB chimeric protein is processed in transfected cells into mature PDGFB dimers; stable expression of COL1A1-PDGFB confers growth factor independence and tumorigenicity in nude mice; conditioned medium stimulates fibroblast growth through PDGFB receptor activation; uncleaved COL1A1-PDGFB forms are also mitogenic, indicating both processed and unprocessed forms contribute to transformation.\",\n      \"method\": \"Stable and transient transfection of chimeric cDNA in PS200 and HEK293 cells, anti-PDGFB and anti-COL1A1-PDGFB antibody immunodetection, PDGFB receptor pathway activation assay, nude mouse tumorigenicity assay, mutagenesis of proteolytic cleavage site\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — reconstitution in cell lines with multiple antibody-based readouts, receptor activation assay, in vivo tumorigenicity, and mutagenesis; multiple orthogonal approaches\",\n      \"pmids\": [\"11420709\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"STI571 (imatinib) inhibits the PDGFB autocrine loop driven by COL1A1-PDGFB, reducing growth and reversing the transformed phenotype of COL1A1-PDGFB-expressing cells in vitro and slowing pre-existing tumor growth in vivo; effects are cytostatic (reversible) rather than cytotoxic, unlike the cytotoxic effect on BCR-ABL tumors.\",\n      \"method\": \"STI571 treatment of 5A cell line (COL1A1-PDGFB transfectants), in vitro growth and morphology assay, nude mouse xenograft tumor growth assay, inhibitor washout reversal experiment\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo pharmacological validation; reversibility confirmed; single lab\",\n      \"pmids\": [\"11291071\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"PDGF-B signaling induces cytoplasmic relocalization (nuclear-to-cytoplasmic shuttling) and upregulation of Y-box protein 1 (YB-1) in mesangial cells via the MAPK pathway; RNAi knockdown of YB-1 abolishes the mitogenic effect of PDGF-B, establishing YB-1 as a necessary downstream mediator of PDGF-B-driven mesangial cell proliferation.\",\n      \"method\": \"PDGF-B infusion in vivo, anti-Thy1.1 nephritis model, PDGF aptamer and MEK inhibitor (U0126) treatment, YB-1 immunolocalization, RNAi knockdown with proliferation assay\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway placement via inhibitor and RNAi; in vivo and in vitro corroboration; single lab\",\n      \"pmids\": [\"16093451\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SDF-1α induces PDGF-B expression transcriptionally through the ELK-1 transcription factor binding to the pdgf-b promoter; increased PDGF-B in turn drives differentiation of PDGFR-β+ bone marrow cells into pericytes, establishing SDF-1α→ELK-1→PDGF-B as a pathway controlling pericyte differentiation.\",\n      \"method\": \"PDGF-B mRNA/protein measurement in vitro and in vivo after SDF-1α stimulation, cloning of 2-kb pdgf-b promoter with reporter assay, chromatin immunoprecipitation (ChIP) for ELK-1, in vitro pericyte differentiation assay\",\n      \"journal\": \"Molecular cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP identifies ELK-1 at promoter; promoter-reporter confirms transcriptional mechanism; in vitro differentiation assay; single lab\",\n      \"pmids\": [\"21911740\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"TIE2 mutations causing venous malformations reduce PDGFB production in endothelial cells through chronic, ligand-independent AKT activation; reduced PDGFB secretion is demonstrated both in vitro and ex vivo in patient tissues, providing a mechanism for the paucity of vascular smooth muscle cells in these lesions.\",\n      \"method\": \"Global gene expression profiling of TIE2-mutant ECs, PDGFB mRNA/protein quantification in vitro and ex vivo, AKT pathway inhibition rescue experiment\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pathway inhibition links AKT to PDGFB; both in vitro and ex vivo patient tissue validation; single lab\",\n      \"pmids\": [\"23633549\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"All six analyzed PDGFB loss-of-function mutations causing primary familial brain calcification (PFBC) abolish PDGF-B function either by preventing protein synthesis or by defective binding/stimulation of PDGF-Rβ; Pdgfbret/ret mice (lacking proteoglycan-binding retention motif) develop brain calcifications despite higher pericyte coverage in calcification-prone regions, implicating the tissue-retention function of PDGF-B rather than simple pericyte deficit.\",\n      \"method\": \"In vitro functional analysis of PDGFB mutants (receptor binding and autophosphorylation assays), mouse knockout and knockin models (Pdgfbret/ret), pericyte coverage quantification, BBB permeability assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple PDGFB mutations functionally characterized in vitro; mechanistic dissection with multiple mouse models; multi-method approach\",\n      \"pmids\": [\"26599395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PDGFB secreted by lymphatic endothelial cells (LECs) of collecting vessels is required for smooth muscle cell (SMC) recruitment to lymphatic vessels; LEC-specific deletion of Pdgfb prevents SMC investment, causing dilation and loss of pulsatile contraction without affecting vessel identity; PDGFB extracellular matrix retention (via its ECM-binding motif) is required for SMC recruitment, as overexpression in LECs fails to induce SMC coverage of capillaries where PDGFB-binding ECM components are scarce.\",\n      \"method\": \"LEC-specific Pdgfb conditional knockout mice, PDGFB overexpression in LECs, vessel morphology and pulsatile contraction analysis, ECM retention mutant analysis\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO with defined vascular phenotype; overexpression confirms requirement for ECM retention motif; multiple vascular beds examined\",\n      \"pmids\": [\"28851707\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"PDGF-B (via v-sis) induces Egr-1 expression through a pathway involving tyrosine kinase activity and c-Ha-Ras signaling: dominant-negative Ras and Raf abolish Egr-1 induction by v-sis; the pathway is independent of PKC; Egr-1 promoter activity is stimulated by both v-sis and activated Ras but not by constitutively active Ras.\",\n      \"method\": \"Inducible v-sis NIH3T3 cells (metallothionein promoter), dominant-negative Ras and Raf mutant co-transfection, Egr-1 promoter-reporter assay, Zn2+ dose-response\",\n      \"journal\": \"Journal of cellular biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis with dominant-negative mutants; promoter-reporter and endogenous gene expression correlated; single lab\",\n      \"pmids\": [\"7890805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PDGF-B deficiency (Pdgfbret/ret mouse, loss of proteoglycan-binding retention motif) suppresses glymphatic system development; formation of astrocytic endfeet and polarized AQP4 expression coincides with the emergence of perivascular CSF transport, and PDGF-B is required for this developmental process.\",\n      \"method\": \"Pdgfbret/ret mouse model, CSF tracer injection/imaging of perivascular transport, AQP4 polarization immunostaining, developmental time-course analysis\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined mouse genetic model with specific functional readout (perivascular CSF flow); correlative with AQP4 polarization; single lab\",\n      \"pmids\": [\"30865886\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Platelet-specific conditional knockout of PDGFB impairs pericyte coverage and tumor vascular function, increases hypoxia and EMT in primary tumors, elevates circulating tumor cells, and increases spontaneous metastasis, establishing platelet-derived PDGFB as a source that maintains vascular integrity via pericyte recruitment in tumors.\",\n      \"method\": \"Platelet-specific conditional Pdgfb knockout mice, tumor pericyte coverage quantification, tumor vascular function assays, circulating tumor cell measurement, spontaneous metastasis assay in two mouse models\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO; multiple vascular and metastatic readouts; two independent mouse tumor models\",\n      \"pmids\": [\"32586981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Microglia constitutively release PDGFB, which signals via PDGFRα on hypothalamic pre-sympathetic neurons to promote Kv4.3 (potassium channel) expression; ablation of microglia or microglial-specific deletion of Pdgfb reduces neuronal Kv4.3, increases neuronal excitability and sympathetic outflow, causing hypertension; central PDGFB supplementation suppresses hypertensive responses.\",\n      \"method\": \"Microglial ablation, LysM-Cre conditional Pdgfb knockout, neuronal PDGFRα knockdown in PVN, electrophysiology, Kv4.3 expression analysis, blood pressure measurement, exogenous PDGFB infusion\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal genetic models (ablation, conditional KO, receptor knockdown); electrophysiology confirms neuronal excitability change; rescue experiment with exogenous PDGFB\",\n      \"pmids\": [\"35863346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Macrophage-derived PDGF-B mediates hypoxia-induced distal arteriole muscularization (SMC accumulation) in pulmonary hypertension; hypoxia-inducible factors (HIF-1α/HIF-2α) in macrophages drive Pdgfb upregulation; LysM-Cre conditional deletion of macrophage Pdgfb reduces muscularization and PH; nanoparticle siRNA delivery targeting lung macrophage Pdgfb prevents PH.\",\n      \"method\": \"Clodronate macrophage depletion, LysM-Cre conditional HIF-1α, HIF-2α, and Pdgfb knockout mice, VHL knockout (HIF gain-of-function) mouse, macrophage-conditioned medium SMC proliferation/migration assay, nanoparticle siRNA delivery, right heart catheterization\",\n      \"journal\": \"JCI insight\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent genetic models; cell-type-specific KO with defined PH phenotype; conditioned medium mechanistic assay; therapeutic rescue with siRNA nanoparticles\",\n      \"pmids\": [\"33591958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Adult-induced endothelial deletion of Pdgfb causes slowly progressing pericyte loss (~50% endothelial:pericyte ratio decrease at 12-18 months) with increased BBB permeability; unlike constitutive loss, adult-induced loss does not cause vessel dilation, arterio-venous skewing, or microvascular calcifications, establishing that developmental vs. maintenance roles of PDGFB are distinct.\",\n      \"method\": \"Tamoxifen-inducible endothelial Cre Pdgfb conditional knockout (2-month-old mice), longitudinal pericyte coverage quantification, BBB permeability assay, vessel morphology analysis, comparison with constitutive Pdgfb knockout\",\n      \"journal\": \"Journal of cerebral blood flow and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — temporally controlled conditional KO with longitudinal readouts; direct comparison with constitutive KO dissects developmental vs. maintenance functions; multiple quantitative endpoints\",\n      \"pmids\": [\"34689641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In adult mice, microglia (not endothelial cells) are the primary source of PDGFB for BBB maintenance; acute deletion of microglial PDGFB profoundly impairs adult BBB integrity and causes fatal microhemorrhages after sublethal endotoxin challenge, while acute abrogation of endothelial PDGFB has minimal adult BBB effect but severely impairs neonatal CNS vasculature; microglia upregulate PDGFB in response to various BBB insults.\",\n      \"method\": \"Transcriptomic analysis and in situ hybridization for PDGFB source identification, acute microglial Pdgfb conditional knockout, acute endothelial Pdgfb conditional knockout in adults and neonates, BBB integrity assay, endotoxin challenge survival assay\",\n      \"journal\": \"Brain, behavior, and immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional KO in adults vs. neonates; multiple genetic models; in situ hybridization for source; functional BBB and survival readouts\",\n      \"pmids\": [\"37992789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"E2F1 transcriptionally activates PDGF-B expression through a positive feedback loop with VEGF-C/VEGFR-3: E2F1 or VEGFR-3 knockdown reduces PDGF-B levels, while coexpression of E2F1 and VEGFR-3 synergistically upregulates PDGF-B promoter activity and endogenous protein expression.\",\n      \"method\": \"E2F1 forced expression and knockdown, VEGFR-3 knockdown, PDGF-B promoter-reporter assay, Western blot for endogenous PDGF-B, in vivo neovascularization assay in mice\",\n      \"journal\": \"Journal of molecular cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter-reporter and knockdown of upstream regulators; synergistic coexpression; in vivo corroboration; single lab\",\n      \"pmids\": [\"24014887\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PROX1 transcriptionally represses PDGF-B expression in valvular endothelial cells partly via FOXC2; conditional deletion of Prox1 in VECs upregulates PDGF-B and PDGF-B overexpression in VECs recapitulates myxomatous valve degeneration; pharmacological inhibition of PDGF-B signaling with imatinib partially rescues the Prox1 knockout valve phenotype.\",\n      \"method\": \"Conditional Prox1 knockout in VECs, conditional FOXC2 knockdown, conditional PDGF-B overexpression in VECs, echocardiography, histology, imatinib pharmacological rescue, RNAScope, human mitral valve prolapse sample analysis\",\n      \"journal\": \"Circulation research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent genetic models; pharmacological rescue; human tissue validation; multiple orthogonal phenotypic readouts\",\n      \"pmids\": [\"37555328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"C/EBPβ directly binds to and transactivates the PDGFB promoter in anoikis-resistant gastric cancer cells, increasing PDGFB secretion; secreted PDGFB promotes survival of detached cancer cells via a C/EBPβ-dependent self-feedback loop (autocrine) and promotes angiogenesis via activation of MAPK/ERK signaling in vascular endothelial cells (paracrine).\",\n      \"method\": \"PDGFB promoter ChIP and transcription assay with C/EBPβ, PDGFB secretion quantification, autocrine survival assay in suspension, paracrine endothelial MAPK/ERK activation assay, in vivo peritoneal metastasis models\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP confirms direct promoter binding; functional autocrine and paracrine assays; in vivo validation; single lab\",\n      \"pmids\": [\"34341514\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Cyclic mechanical strain increases PDGF-B mRNA and PDGFB promoter activity (~12-fold) and PDGF-β receptor protein (~1.8-fold) in vascular smooth muscle cells; neutralizing antibodies to the PDGF-β receptor reduce strain-induced DNA synthesis by 50%, establishing PDGF-B as a mediator of mechanically induced VSMC proliferation.\",\n      \"method\": \"Cyclic strain apparatus, PDGFB-promoter-CAT reporter transfection, Northern blot, PDGF-β receptor protein immunoblot, neutralizing antibody inhibition of 3H-thymidine incorporation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — promoter-reporter and receptor antibody blockade mechanistically link mechanical strain to PDGF-B-dependent proliferation; single lab, multiple methods\",\n      \"pmids\": [\"10558917\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PDGFB (c-sis) encodes the B chain of PDGF, which is synthesized as a precursor in the ER-Golgi (where signal cleavage and glycosylation occur), secreted as a disulfide-linked dimer, and acts by binding and activating the PDGF receptor tyrosine kinase at the cell surface to drive autocrine/paracrine mitogenic and chemotactic signaling; v-sis-driven transformation can additionally occur through intracellular (pre-surface) receptor activation; endothelial cell- and microglia-derived PDGFB recruits and maintains pericyte coverage (requiring ECM retention via a proteoglycan-binding motif) to sustain blood-brain barrier integrity and vascular stabilization; transcriptional regulation involves PKC, TGF-β, and mechanical strain via defined promoter elements (SPE); in tumors the COL1A1-PDGFB fusion places PDGFB under constitutive expression, generating an autocrine PDGFRβ loop driving dermatofibrosarcoma protuberans; and microglia-derived PDGFB additionally signals through neuronal PDGFRα to maintain Kv4.3-mediated potassium currents and suppress sympathetic tone.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PDGFB (c-sis) encodes the B chain of platelet-derived growth factor, a secreted disulfide-linked dimeric mitogen that signals through cell-surface PDGF receptor tyrosine kinases to drive proliferative and chemotactic responses [#0, #1]. The protein is matured through the ER-Golgi, where signal-sequence cleavage and N-linked glycosylation occur; it contains no transmembrane region, and proper signal-sequence-dependent trafficking is required for biological activity [#3]. In its viral oncogene form (v-sis), the product transforms cells by binding and autophosphorylating the PDGF receptor and inducing DNA synthesis, with transformation strictly contingent on receptor presence in the target cell and reversible by selective PDGF-receptor kinase inhibitors [#1, #2, #12]; this activating ligand-receptor interaction normally occurs at the plasma membrane, since blocking secretion or surface binding abolishes receptor autophosphorylation and c-fos induction, yet ER-retained, non-secreted mutants can also transform, demonstrating an additional intracellular autoactivation route [#5, #6]. Downstream, PDGF-B engages a Ras/Raf-dependent, PKC-independent cascade to induce immediate-early genes and activates a dedicated sis-inducible factor (SIF) acting on the c-fos promoter independently of the serum-responsive element [#9, #21]. Physiologically, PDGFB recruits and maintains mural-cell coverage of the vasculature: endothelial-, platelet-, microglia-, macrophage-, and lymphatic-endothelial-derived PDGFB directs pericyte and smooth-muscle-cell investment to stabilize blood vessels, with extracellular-matrix retention via its proteoglycan-binding motif essential for this recruitment [#19, #20, #23, #25]. Microglia are the principal source sustaining adult blood-brain-barrier integrity, and loss-of-function PDGFB mutations that prevent synthesis or PDGFRβ binding cause primary familial brain calcification [#19, #27]. PDGFB transcription is controlled by phorbol ester/PKC, TGF-β, mechanical strain, and defined factors acting on promoter elements including the SIS proximal element [#8, #11, #31]. In dermatofibrosarcoma protuberans, a COL1A1-PDGFB fusion places PDGFB under constitutive COL1A1-driven expression, generating an autocrine PDGFRβ loop that confers tumorigenicity and is sensitive to imatinib [#13, #14, #15].\",\n  \"teleology\": [\n    {\n      \"year\": 1984,\n      \"claim\": \"Establishing that the c-sis proto-oncogene encodes the PDGF B chain unified a transforming retroviral gene with a known mitogen, defining the molecular identity of PDGFB.\",\n      \"evidence\": \"Direct amino acid sequencing of purified PDGF B chain matched to c-sis genomic sequence\",\n      \"pmids\": [\"6329745\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address how the secreted protein engages receptors or drives transformation\", \"No information on physiological tissue source\"]\n    },\n    {\n      \"year\": 1985,\n      \"claim\": \"Demonstrating that the v-sis product binds the PDGF receptor, stimulates receptor tyrosine phosphorylation, and requires receptor presence for transformation defined an autocrine surface-receptor mechanism for sis-driven growth.\",\n      \"evidence\": \"Receptor binding, tyrosine phosphorylation, and DNA-synthesis assays with antibody inhibition and receptor-positive vs -negative cells\",\n      \"pmids\": [\"6091918\", \"2996133\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve where activation occurs in the cell\", \"Did not identify downstream effectors\"]\n    },\n    {\n      \"year\": 1986,\n      \"claim\": \"Mapping the secretory processing route established that PDGFB matures through the ER-Golgi with signal cleavage and glycosylation and that correct trafficking is required for activity.\",\n      \"evidence\": \"Site-directed mutagenesis, microsome trypsin-protection, fractionation, immunofluorescence and transformation assays; membrane-anchored fusion analysis\",\n      \"pmids\": [\"3537701\", \"3536965\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the proteoglycan-binding/ECM-retention function later shown to be essential\", \"Membrane-anchored form work is single-lab Medium confidence\"]\n    },\n    {\n      \"year\": 1988,\n      \"claim\": \"Pharmacological blockade of secretion and surface binding localized the active signaling event to the plasma membrane, testing whether autocrine activation is intracellular or extracellular.\",\n      \"evidence\": \"Inducible v-sis expression with monensin/suramin and receptor autophosphorylation/c-fos readouts\",\n      \"pmids\": [\"2455725\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Apparently contradicted by later ER-retention transformation data\", \"Did not quantify relative contribution of surface vs internal routes\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"ER-retained, non-secreted v-sis mutants that still transform demonstrated an intracellular pre-surface receptor-activation route, qualifying the strict surface-only model.\",\n      \"evidence\": \"ER-retention signal mutagenesis, transformation assay, anti-PDGF antisera failing to reverse transformation\",\n      \"pmids\": [\"2551043\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the subcellular site of intracellular activation\", \"Relevance of internal activation to non-viral PDGFB unclear\"]\n    },\n    {\n      \"year\": 1990,\n      \"claim\": \"Identification of a sis-inducible factor and the SIF promoter element defined a PDGF-B-specific transcriptional output distinct from the serum-response pathway.\",\n      \"evidence\": \"Recombinant PDGF-B induction, gel-shift, and c-fos promoter-reporter deletion analysis\",\n      \"pmids\": [\"2176154\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not molecularly identify the SIF protein\", \"Receptor-to-SIF signaling steps not defined\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Genetic and pharmacological dissection placed PDGF-B signaling in a Ras/Raf-dependent, PKC-independent cascade and confirmed transformation runs specifically through PDGF-receptor kinase.\",\n      \"evidence\": \"Dominant-negative Ras/Raf in Egr-1 induction assays; selective tyrphostin reversion of sis-transformed cells with kinase-specificity profiling\",\n      \"pmids\": [\"7890805\", \"7954456\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map full downstream effector network\", \"Egr-1 epistasis is single-lab Medium confidence\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Promoter dissection showed phorbol ester/PKC-, TGF-β-, and strain-responsive elements—including the SIS proximal element—control PDGFB transcription, defining its inducible regulation.\",\n      \"evidence\": \"Nuclear run-on, linker-scanning/deletion promoter mutagenesis, reporter and gel-shift assays, cycloheximide blockade; 5'UTR translational control\",\n      \"pmids\": [\"8356057\", \"2655888\", \"3466024\", \"2740212\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the SPE-binding factor not established\", \"Mostly single-cell-type, single-lab analyses\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Characterizing recurrent COL1A1-PDGFB fusions in DFSP showed how PDGFB is placed under constitutive COL1A1-promoter control with loss of its negative regulatory elements, linking PDGFB deregulation to a defined tumor.\",\n      \"evidence\": \"RT-PCR, sequencing, Southern blotting and breakpoint mapping across 16 DFSP/GCF tumors\",\n      \"pmids\": [\"9739023\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Processing/functional consequence of exon-2 retention not directly tested here\", \"Did not demonstrate autocrine loop functionally\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Reconstitution proved the COL1A1-PDGFB chimera is processed to active PDGFB dimers driving an autocrine PDGFRβ loop conferring tumorigenicity, and that imatinib reverses this transformed phenotype.\",\n      \"evidence\": \"Stable/transient transfection, antibody immunodetection, receptor-activation assays, nude-mouse tumorigenicity, cleavage-site mutagenesis; STI571 treatment with washout reversal in vitro and in vivo\",\n      \"pmids\": [\"11420709\", \"11291071\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Imatinib effect is cytostatic and from a single lab\", \"Contribution of uncleaved vs processed forms not fully quantified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Cell-type-specific deletion established that PDGFB recruits mural cells (pericytes, smooth muscle) and that its ECM-retention motif is required, defining the physiological vascular-stabilization function across vascular beds.\",\n      \"evidence\": \"LEC-specific Pdgfb conditional knockout, overexpression, ECM-retention mutant analysis, and vessel morphology/contraction phenotyping\",\n      \"pmids\": [\"28851707\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address adult maintenance vs developmental roles\", \"Mechanism of ECM-dependent local gradient formation not detailed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Loss-of-function mutation analysis and Pdgfbret/ret mice tied PDGFB to primary familial brain calcification and showed the tissue-retention function, not pericyte number alone, underlies the disease.\",\n      \"evidence\": \"In vitro receptor binding/autophosphorylation of patient mutants, knockout/knockin mouse models, pericyte and BBB readouts; glymphatic CSF-transport analysis\",\n      \"pmids\": [\"26599395\", \"30865886\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism linking retention loss to calcification not fully resolved\", \"Glymphatic findings are single-lab Medium confidence\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Cell-source dissection in adults revealed microglia—not endothelium—as the principal PDGFB source maintaining the adult blood-brain barrier, distinguishing developmental from maintenance functions.\",\n      \"evidence\": \"Transcriptomics/in situ source identification, acute microglial vs endothelial and adult vs neonatal conditional knockouts, BBB integrity and endotoxin-challenge survival; tamoxifen-inducible endothelial knockout comparison with constitutive loss; macrophage- and platelet-derived sources in pulmonary hypertension and tumor metastasis\",\n      \"pmids\": [\"37992789\", \"34689641\", \"32586981\", \"33591958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How distinct cellular sources are coordinated in vivo not resolved\", \"Signals triggering microglial PDGFB upregulation incompletely defined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying a microglia→neuronal PDGFRα axis controlling Kv4.3 currents extended PDGFB function beyond mitogenesis to neuronal excitability and blood-pressure control.\",\n      \"evidence\": \"Microglial ablation, LysM-Cre Pdgfb knockout, neuronal PDGFRα knockdown, electrophysiology, blood pressure measurement, exogenous PDGFB rescue\",\n      \"pmids\": [\"35863346\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular link between PDGFRα signaling and Kv4.3 expression not defined\", \"Single-system finding\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Mapping upstream transcriptional regulators (SDF-1α/ELK-1, E2F1/VEGFR-3, C/EBPβ, PROX1/FOXC2, TIE2/AKT) placed PDGFB within multiple disease-relevant regulatory circuits.\",\n      \"evidence\": \"ChIP, promoter-reporter, knockdown/overexpression, conditional knockouts, pharmacological rescue, and human tissue validation across pericyte differentiation, vascular malformation, valve degeneration, and cancer contexts\",\n      \"pmids\": [\"21911740\", \"24014887\", \"34341514\", \"37555328\", \"23633549\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cross-talk among these regulators not integrated\", \"Several individual circuits are single-lab Medium confidence\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PDGFB integrates its multiple cellular sources, ECM-dependent local retention, and receptor choice (PDGFRβ on mural cells vs PDGFRα on neurons) into context-specific outputs remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of source-specific PDGFB function in vivo\", \"Molecular determinant selecting PDGFRα vs PDGFRβ engagement unknown\", \"Identity of the SPE/SIF transcription and signaling proteins not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [0, 1, 2, 19]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 2, 5, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [3, 6]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [3, 4]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 5, 20]},\n      {\"term_id\": \"GO:0031012\", \"supporting_discovery_ids\": [19, 20]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 9, 21]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [19, 20, 26]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 14, 19, 25]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [8, 11, 17, 28, 29, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PDGFRB\", \"PDGFRA\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}